Description

Thymopentin For Injection (10?mg) is a synthetic pentapeptide derived from the active fragment of thymopoietin, consisting of arginine, lysine, aspartic acid, valine, and tyrosine. It acts as a powerful immunomodulator by promoting differentiation and maturation of T cells, enhancing cytokine production, and restoring immune competence. Manufactured to pharmaceutical standards in sterile injectable format under Chinese licence H20067994, this product is widely used in research focusing on immune deficiency, chronic infections, and as an adjuvant in experimental cancer models. Supplied in single-use vials of 10?mg. For research use only.

Product Specifications

Mechanism of Action & Research Applications

Thymopentin For Injection mimics the active site of thymopoietin, modulating T-cell differentiation and adaptive immunity by binding precursor T?cells and promoting cytokine release (such as interleukin?2 and interferon?gamma). It has demonstrated immune-enhancing activity in models of immunodeficiency, chronic hepatitis, autoimmune disease, and as an adjuvant in tumor immunotherapy ([turn0search1]). In research, it is used to study restoration of immunocompetence, immune reconstitution, infection response, and synergy with chemotherapy agents. This peptide has also been explored for effects on cancer stem cell markers and immune checkpoint modulation in preclinical studies ([turn0search12]). Intended strictly for laboratory research use.

Side Effects (For Reference Only in Models)

In controlled model systems, potential effects may include mild injection site reactions, transient immune activation, cytokine shifts, fatigue-like responses, or altered hematological parameters. Rare overstimulation of immune activity may occur in dose escalation protocols. These observations can guide experimental safety monitoring and dose design.

Disclaimer

Thymopentin For Injection 10?mg is strictly intended for laboratory research use only. Not for human or veterinary therapeutic use.